Study: Tumors inhibit immune system

May 29, 2006

Seattle scientists have shown that tumors can manipulate the immune system to stop it from attacking cancer cells, said a study published in Nature Immunology.

Tumors produce abnormal proteins that cause normally helpful immune cells to inhibit attempts by the immune system to attack the cancer, instead of aiding the mobilization of the immune systems defenses.

The study by Seattle's Fred Hutchinson Cancer Research Center found one of these proteins changes the role of otherwise helpful immune cells, called T helper cells, which in the early stages of the disease play a key role in the body's efforts to destroy cancer cells.

In response to the tumor-derived soluble form of the protein, the cells divide and take on a suppressor role, reducing the anti-cancer potency of the immune system, the report said, but exactly how the T helper cells become suppressor cells is not yet known.

Lead researcher Dr. Thomas Spies said, "If one could prevent a tumor from producing the soluble protein it could be beneficial in terms of helping sustain the immune system's normal capacity to mount an anti-tumor response," the BBC reported Monday.

Copyright 2006 by United Press International

Explore further: Cooling of dialysis fluids protects against brain damage

add to favorites email to friend print save as pdf

Related Stories

Marcellus drilling boom may have led to too many hotel rooms

21 minutes ago

Drilling in Pennsylvania's Marcellus Shale region led to a rapid increase in both the number of hotels and hotel industry jobs, but Penn State researchers report that the faltering occupancy rate may signal that there are ...

Recommended for you

Cooling of dialysis fluids protects against brain damage

49 minutes ago

While dialysis can cause blood pressure changes that damage the brain, cooling dialysis fluids can protect against such effects. The findings come from a study appearing in an upcoming issue of the Journal of the American So ...

Two Ebola vaccines to be tested in Switzerland

1 hour ago

Clinical trials of two experimental vaccines against the deadly Ebola virus are due to begin soon in Switzerland, the country's Tropical and Public Health Institute said on Thursday.

User comments : 0